Cancer Vaccines
Telomerase Presentations At the AACR 2007 Annual Meeting
Published in Vaccine Weekly, May 16th, 2007
Geron Corporation (Nasdaq: GERN) today referenced multiple presentations on the role of telomerase and telomeres in cancer at this year's American Association for Cancer Research (AACR) Annual Meeting in Los Angeles. There were approximately 80 presentations on telomere and telomerase biology reflecting the growing body of evidence supporting the importance of telomerase as a universal cancer target for drug and vaccine development. Geron holds key intellectual property in the field and leads the development of telomerase-based cancer therapeutics with a drug, GRN163L, and a vaccine, GRNVAC1, in human clinical trials.
Telomerase and Cancer
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-05-16)
More Articles from Vaccine Weekly
- Sickle Cell Anemia
Serious illness among children with sickle cell disease reduced with vaccine - Autism
NAA and SafeMinds Call for Increased Environmental Research on Autism at IOM Workshop - Bird Flu
CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals - Bird Flu
LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization - Bird Flu
Purdue Research Foundation Licenses New Flu Vaccine Candidate to PaxVax - Cancer Vaccines
Advaxis Announces Completion of Patient Accrual in Lovaxin C Phase I/II Trial - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
